Viatris (VTRS) Change in Acquisitions & Divestments (2020 - 2026)
Viatris' (VTRS) quarterly Change in Acquisitions & Divestments came in at $7.5 million in Q1 2026, up 29.31% quarter-over-quarter from $5.8 million in Q4 2025.
Viatris (VTRS) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends
Viatris' Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $7.5 million for Q1 2026.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $7.5 million in Q1 2026; TTM through Mar 2026 was $31.4 million, a 71.58% increase from a year earlier, with the FY2025 full-year figure at $23.9 million, down 8.08% from the prior year.
- Change in Acquisitions & Divestments climbed to $7.5 million in Q1 2026 per VTRS's latest filing, from $5.8 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $10.9 million in Q2 2025 and bottomed at $4.3 million in Q3 2023.
- The 5-year median for Change in Acquisitions & Divestments is $7.4 million (2025), against an average of $7.1 million.
- Across the five-year window, Change in Acquisitions & Divestments slumped 57.84% in 2023 and jumped 95.35% in 2024, its largest moves.
- Year by year, Change in Acquisitions & Divestments stood at $6.9 million in 2022, then retreated by 21.74% to $5.4 million in 2023, then declined by 20.37% to $4.3 million in 2024, then jumped by 34.88% to $5.8 million in 2025, then advanced by 29.31% to $7.5 million in 2026.
- Per Business Quant, the three latest VTRS Change in Acquisitions & Divestments figures stand at $7.5 million (Q1 2026), $5.8 million (Q4 2025), and $7.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.50 Mn |
| Mar 31, 2026 | 7.50 Mn |
| Dec 31, 2025 | 5.80 Mn |
| Dec 31, 2025 | 5.80 Mn |
| Sep 30, 2025 | 7.20 Mn |
| Sep 30, 2025 | 7.20 Mn |
| Jun 30, 2025 | 10.90 Mn |
| Jun 30, 2025 | 10.90 Mn |
| Dec 31, 2024 | 4.30 Mn |
| Dec 31, 2024 | 4.30 Mn |
| Sep 30, 2024 | 8.40 Mn |
| Sep 30, 2024 | 8.40 Mn |
| Jun 30, 2024 | 5.60 Mn |
| Jun 30, 2024 | 5.60 Mn |
| Mar 31, 2024 | 7.70 Mn |
| Mar 31, 2024 | 7.70 Mn |
| Dec 31, 2023 | 5.40 Mn |
| Dec 31, 2023 | 5.40 Mn |
| Sep 30, 2023 | 4.30 Mn |
| Sep 30, 2023 | 4.30 Mn |